Literature DB >> 24997859

Diagnosis of hepatocellular carcinoma.

V Cartier1, C Aubé2.   

Abstract

More than 90% of cases of hepatocellular carcinoma occur on the background of chronic liver disease. Its diagnosis should therefore be based on six-month ultrasound screening, which should be started in these patients. The positive diagnosis of hepatocellular carcinoma is based on its vascularization examined on dynamic CT or MRI images after contrast enhancement. Arterial hypervascularization followed by a washout from the lesion in the portal and/or late phases on a background of cirrhosis provides a positive diagnosis of HCC without histology for nodules over a centimeter in size (international guidelines). Any other appearances require needle biopsy of the nodule and extra-nodular area to confirm the diagnosis. The local staging assessment predominantly involving portal invasion and the general patient assessment should be combined with assessment of the underlying liver disease to guide the treatment decision. The information obtained should be contained in as standardized a report as possible with all of the information required for patient management.
Copyright © 2014 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Carcinoma; Hepatocellular; Liver disease; MRI; Ultrasound

Mesh:

Year:  2014        PMID: 24997859     DOI: 10.1016/j.diii.2014.06.004

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  4 in total

Review 1.  Radiomics of hepatocellular carcinoma.

Authors:  Sara Lewis; Stefanie Hectors; Bachir Taouli
Journal:  Abdom Radiol (NY)       Date:  2021-01

2.  PRM-MS Quantitative Analysis of Isomeric N-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma.

Authors:  Cristian D Gutierrez Reyes; Yifan Huang; Mojgan Atashi; Jie Zhang; Jianhui Zhu; Suyu Liu; Neehar D Parikh; Amit G Singal; Jianliang Dai; David M Lubman; Yehia Mechref
Journal:  Metabolites       Date:  2021-08-23

3.  Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma.

Authors:  In Young Jo; Seok-Hyun Son; Myungsoo Kim; Soo Yoon Sung; Yong Kyun Won; Hye Jin Kang; So Jung Lee; Yong-An Chung; Jin Kyoung Oh; Chul-Seung Kay
Journal:  Radiat Oncol J       Date:  2015-09-30

Review 4.  Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles.

Authors:  Hong Kiat Lim; Gary P Jeffrey; Grant A Ramm; Carolina Soekmadji
Journal:  Front Cell Infect Microbiol       Date:  2020-11-10       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.